Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Saturday, February 22, 2025.
Arbutus Biopharma Corporation (NASDAQ:ABUS)
Crossroads (+60) - ABUS is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid ABUS?
MarketClub looks at technical strength and momentum to determine if the timing is right for ABUS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for ABUS
The long-term trend has been DOWN since Dec 3rd, 2024 at 3.385
The intermediate-term trend has been UP since Feb 5th, 2025 at 3.445
The short-term trend has been UP since Feb 18th, 2025 at 3.360
Smart Scan Analysis for ABUS
Based on our trend formula, ABUS is rated as a +60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 3.480 | 3.515 | 3.400 | 3.420 | -0.020 |
| Prev. Close | Volume | Bid | Ask | Time |
| 3.420 | 832051 | 2025-02-21 15:59:55 |
| Year High | 12.6 | Year High Date | 2018-08-02 |
| Year Low | 4.01 | Year Low Date | 2018-10-15 |
| 52wk High | 4.725 | 52wk High Date | 2024-09-09 |
| 52wk Low | 2.3 | 52wk Low Date | 2024-04-03 |
| Average Volume | 641,694 | Shares Outstanding | 189,492 |
| Market Cap | 103M | Assets | 140,441,000M |
| Liabilities | 33,551,000M | P/E Ratio | -3.08220000 |
| Volatility | 102.46 |